Live Breaking News & Updates on Endoscopy Outcomes

Stay updated with breaking news from Endoscopy outcomes. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

New STELARA® (ustekinumab) Long-Term Data Support its Established Safety Profile in Inflammatory Bowel Disease and Durable Efficacy in Ulcerative Colitis

/PRNewswire/ The Janssen Pharmaceutical Companies of Johnson & Johnson today announced final pooled long-term safety results for STELARA® (ustekinumab). ....

Spring House , British Columbia , United States , Waqqas Afif , Jan Wehkamp , Colitis Organization , Division Of Experimental Medicine , Crohn Colitis Foundation , Janssen Research Development , Janssen Pharmaceutical Companies , Janssen Pharmaceutical Companies Of Johnson , Department Of Medicine , University Health Centre , None Of The Janssen Pharmaceutical Companies , Division Of Gastroenterology , National Institutes Of Health , Exchange Commission , Companies Of Johnson , Crohn Colitis Foundation Of America , European Crohn , Associate Professor , Experimental Medicine , Vice President , Gastroenterology Disease Area Leader , Janssen Research , Global Assessment ,